374 related articles for article (PubMed ID: 16931540)
21. In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.
Boucher HW; Thauvin-Eliopoulos C; Loebenberg D; Eliopoulos GM
Antimicrob Agents Chemother; 2001 Jan; 45(1):208-11. PubMed ID: 11120967
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
Castañeda X; García-De-la-Mària C; Gasch O; Pericàs JM; Soy D; Cañas-Pacheco MA; Falces C; García-González J; Hernández-Meneses M; Vidal B; Almela M; Quintana E; Tolosana JM; Fuster D; Llopis J; Dahl A; Moreno A; Marco F; Miró JM;
J Antimicrob Chemother; 2021 May; 76(6):1539-1546. PubMed ID: 33837406
[TBL] [Abstract][Full Text] [Related]
23. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.
Dhawan VK; Yeaman MR; Bayer AS
J Infect Dis; 1999 Nov; 180(5):1561-8. PubMed ID: 10515816
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus.
Vaudaux P; Francois P; Bisognano C; Li D; Lew DP; Schrenzel J
J Antimicrob Chemother; 2003 Jul; 52(1):89-95. PubMed ID: 12775678
[TBL] [Abstract][Full Text] [Related]
25. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
[TBL] [Abstract][Full Text] [Related]
26. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
Lodise TP; McKinnon PS; Levine DP; Rybak MJ
Antimicrob Agents Chemother; 2007 Oct; 51(10):3731-3. PubMed ID: 17664322
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy evaluation of cloxacillin and cloxacillin-gentamicin in an experimental model of methicillin-sensitive Staphylococcus aureus].
Apellaniz Sainz-Trapaga G; Valdes Chavarri M; Pérez Costa R; Martín Luengo F; García Alberola A; Soria Arcos F; Gómez Gómez J
An Med Interna; 1991 Mar; 8(3):124-7. PubMed ID: 1893018
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
29. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
Climo MW; Patron RL; Goldstein BP; Archer GL
Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
[TBL] [Abstract][Full Text] [Related]
30. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.
de Górgolas M; Avilés P; Verdejo C; Fernández Guerrero ML
Antimicrob Agents Chemother; 1995 Apr; 39(4):953-7. PubMed ID: 7786002
[TBL] [Abstract][Full Text] [Related]
31. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
[TBL] [Abstract][Full Text] [Related]
32. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
[TBL] [Abstract][Full Text] [Related]
33. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
Olay T; Vicente MV; Rodríguez A
J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
[No Abstract] [Full Text] [Related]
35. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin minimum inhibitory concentration in methicillin-susceptible Staphylococcus aureus and mortality: more than handwaving?
Kaasch AJ; Jung N; Fätkenheuer G; Seifert H
Clin Infect Dis; 2015 Feb; 60(4):668. PubMed ID: 25371487
[No Abstract] [Full Text] [Related]
37. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S
J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473
[TBL] [Abstract][Full Text] [Related]
39. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.
Rose WE; Rybak MJ; Kaatz GW
J Antimicrob Chemother; 2007 Aug; 60(2):334-40. PubMed ID: 17540670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
